Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HLT Medical is a U.S.-based medical device company focused on transcatheter heart valve technologies for structural heart disease. The company developed transcatheter aortic valve replacement (TAVR) technology, centered on the Meridian valve system, designed to improve physician control, positioning, and retrievability during implantation. Available third-party descriptions characterize HLT as a clinical-stage or development-stage medtech company headquartered in Maple Grove, Minnesota. The business appears to have operated in cardiovascular devices rather than therapeutics, with its lead product aimed at treating aortic valve disease. Recent third-party data suggest the company is no longer actively operating as an independent growth-stage business despite its legal entity remaining active in some records.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HLT Medical.